Friday, 17 Nov 2017

You are here

High Drug Discontinuations and Nonadherence in Fibromyalgia

Compliance and adherence was shown to be quite poor in fibromyalgia (FM) patients, with high rates of drug discontinuation and greater than 60% demonstrated low adherence.

Using claims data from a  large, Israeli, health maintenance organization 3922 FM were assessed from 2008 through 2011; specifically looking at the following agents over a 12 month period: pregabalin, antidepressants [selective serotonin reuptake inhibitor (SSRI), serotonin/norepinephrine reuptake inhibitor (SNRI)], and tricyclic antidepressants (TCA).

The proportion of days covered (PDC) was used as a measure of drug adherence. A PDC < 20% was considered low adherence and PDC ≥ 80% was considered high adherence. 

Of the 56.1% issued a qualifying prescription, 45.0% were dispensed at least 1 medication in the year following diagnosis, and only 28.8% had prescriptions filled twice within the first year from diagnosis.

The 1-year drug discontinuation was highest for TCA (91.0%) and lowest for SSRI/SNRI antidepressants (73.7%).

Over half of the patients (60.5%) had fewer than 20% of the days covered by any medication during the year and only 9.3% were very adherent (PDC ≥ 80%).

FM management may be confounded and complicated by high drug discontinuations and low adherence.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Rheumatologists' Comments

These patients are doing the right thing! These meds are adjunctive at best and are not cost effective in terms of money or side effects. The biopsychosocial model of this disorder is the basis for treatment with non-pharmacologic therapies. Since there are no "big bucks" involved with non-pharmacologic treatment, the traditional medical model is a poor substitute that is costly and ineffective. I often have to tell patients that there is no medicine on the planet earth to put between their lips for the pain of fibromyalgia A good rheumatologist screens for medical conditions, provides cognitive therapy and guidance and validation and follows the patient for at least a year in case something changes. A bad rheumatologist diagnoses sero-negative RA and starts Remicade infusions! Medicalization of Misery as Dr. Norton Hadler has written about.

More Like This

DEA Cracks Down on Illicit Fentanyl

Reuters reports that  U.S. Drug Enforcement Administration (DEA) has declaed it would classify illicit versions of fentanyl at the same level as heroin, allowing criminal prosecution of anyone who possesses, distributes or manufactures illicit versions of the drug.

Increasing Deaths and Breaking Bad with Fentanyl

Opioid overdose deaths quadrupled from 1999 to 2015 and accounted for 63% of drug overdose deaths in the United States in 2015. During 2010–2015, heroin overdose deaths quadrupled from 3,036 to 12,989, with heroin and illicitly manufactured fentanyl (IMF) as likely contributors to this trend. (additional citation https://buff.ly/2eHAjpn)

No Evidence to Support Use of Gabapentinoids in Low Back Pain

Management of chronic low back pain (CLBP) is often complex, requiring multiple modalities and meds to control pain. An analysis of studies shows that Gabapentinoids, including pregabalin and gabapentin, have little to no benefits but significant risk of adverse effects.  (Citation source https://buff.ly/2warMSU)

Marijuana Has Little Effect on Most Types of Pain

Cannabis has become a regulated product, and many states have made it available with the intent of treating a variety of medical disorders, including chronic pain. A metanalysis published in Annals of Internal Medicine has shown that while cannabis may help neuropathic pain, it is not proven to benefit other types of chronic pain.

One-Third of Americans Took Opioids in 2015

 In the wake of the well-publicized "opioid epidemic", researchers report in the Annals of Internal Medicine (online July 31) that more than one third of U.S. adults were prescribed opioids in 2015 and that misuse remains a major problem. (Citation source http://buff.ly/2vkd8au)